When has Arna and jl moved up earnings call? Before market opens on monday at 5:30am est. I dont remember when they did this...Earnings are not the thing to look at because no milestones will be reflected in this cc...Eisai has had their launch meeting going on in florida and even JL was there..I dont know but it seems the ducks are lining up nicely..Would the dea give a heads up to Eisai about final and effective? Those meetings are not cheap at all and would want the meeting as close as possible to launch date so as not to lose its mojo...This is the most important launch in Eisai history, a novel new drug for weight loss and diabetic benefits
Sorry, but I disagree payoff...We know the launch is coming and so does the entire market, we will not get a huge pop from it and assume maybe a 3% modest gain when the official word it out from DEA. Now the ER on Monday could be a possible "game" changer...I'm not banking on it being one, ARNA likes to tie good news together and if there are talks about additional partners or even buyout rumor (not likely) you could see that $13, along with shorts covering if big positive news is released Monday. All 3 with a positive CHMP vote come March-June I would say we will be over $13 wtih confidence, but you nor I will see $20 unless we have a huge launch along with CHMP pos vote and a parnter announcement from EU. Short interest along with days to cover are increasing because of the volume dropping, I'm excited for Monday, but don't be disappointed if nothing materializes and we stay range bound in 8's-9.
.We know the launch is coming and so does the entire market, we will not get a huge pop from it
13 days to cover and ARNA has a trainload of unusually big news coming at it. What you may be missing is this stock is trading $4-6 under where it was when they had NO income streams at FDA approval. ARNA is trading too low for ANYONE to be short here and you all are forgetting the squeeze potential.
A lot of pent up interest in whether or not the launch will happen. There was always a chance the someone could have thrown in the red flag during the response period. Its not over yet so anything can still happen. However, if it goes in favor of ARNA, the roof might just come off. There is a lot at stake for Eisai who is paying ARNA for the rights to market. Eisai has already set the stage for a major launch. With VVUS essentially out of the running now here and in Europe, ARNA is center stage. Big pharma knows it and dont be surprised to see ARNA go to the auction block by 2014.